Summary
Updated Aug 30, 2026
Anders Ullman is Director of Verona Pharma plc (VRNA). 2 SEC Form 4 filings on record, most recently on 7 October 2025.
Recent Transactions
4Every recent SEC Form 4 transaction Anders Ullman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Anders Ullman. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Zaccardelli - $11.26M of VRNA open-market activity on record
- Mark W. Hahn - $11.26M of VRNA open-market activity on record
- Kathleen A. Rickard - $1.94M of VRNA open-market activity on record
- David R. Ebsworth - $303K of VRNA open-market activity on record
- Christina Ackermann - $222K of VRNA open-market activity on record
- Michael Austwick - $148K of VRNA open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Anders Ullman?
Anders Ullman is a corporate insider, tracked as Director of Verona Pharma plc (VRNA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Anders Ullman last file a Form 4?
The most recent primary Form 4 on record is dated 7 October 2025, one of 2 filings going back to 2025.
Where can I see all of Anders Ullman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Anders Ullman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
